BACKGROUND
Neoadjuvant chemotherapy (NAC) followed by surgery is the standard treatment for locally advanced gastric cancer (LAGC). However, post-therapy staging based on ypTNM mainly reflects residual pathological status and does not capture pretreatment disease burden or the extent of tumor regression after NAC, limi...
Wei-Feng Chen, Hua-Long Zheng, Ling-Kang Zhang et al.· European Journal of Surgical...· 0 citations
Objective
To achieve accurate prediction of early recurrence (ER) in locally advanced gastric cancer (LAGC) patients after neoadjuvant therapy (NAT) and surgery, we constructed a deep learning fusion model integrating preoperative computed tomography (CT) imaging and perioperative clinicopathological features.
Method...
Cai-Ming Weng, Q. Zhong, Li-Hong Chen et al.· Chinese journal of cancer re...· 0 citations
This study unveils an MDK-TRPA1 + CAF-mediated mechanism of ICB resistance in GC and highlights the WNT5A-SPP1+ macrophage pathway as a promising target to overcome immunotherapy resistance.
Hua-Long Zheng, Xiao-Qian Ye, Lin-Yong Zheng et al.· Oncogene· 0 citations
These findings establish CTHRC1+ CAFs as a critical stromal determinant of immune exclusion in GC, suggesting that targeting the CTHRC1+ CAF‐MIF axis or applying CRS‐guided patient stratification may enhance immunotherapy efficacy.
Ying-Xin Wu, Ling-han Tang, Ping Li et al.· Human Mutation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.